CD14 Signaling Restrains Chronic Inflammation through Induction of p38-MAPK/SOCS-Dependent Tolerance by Sahay, Bikash et al.
CD14 Signaling Restrains Chronic Inflammation through
Induction of p38-MAPK/SOCS-Dependent Tolerance
Bikash Sahay
1, Rebeca L. Patsey
1, Christian H. Eggers
2¤, Juan C. Salazar
3, Justin D. Radolf
2,4, Timothy J.
Sellati
1*
1Center for Immunology and Microbial Disease, Albany Medical College, Albany, New York, United States of America, 2Department of Medicine, University of
Connecticut Health Center, Farmington, Connecticut, United States of America, 3Connecticut Children’s Medical Center, Division of Pediatric Infectious Diseases, Hartford,
Connecticut, United States of America, 4Department of Genetics and Developmental Biology, University of Connecticut Health Center, Farmington, Connecticut, United
States of America
Abstract
Current thinking emphasizes the primacy of CD14 in facilitating recognition of microbes by certain TLRs to initiate pro-
inflammatory signaling events and the importance of p38-MAPK in augmenting such responses. Herein, this paradigm is
challenged by demonstrating that recognition of live Borrelia burgdorferi not only triggers an inflammatory response in the
absence of CD14, but one that is, in part, a consequence of altered PI3K/AKT/p38-MAPK signaling and impaired negative
regulation of TLR2. CD14 deficiency results in increased localization of PI3K to lipid rafts, hyperphosphorylation of AKT, and
reduced activation of p38. Such aberrant signaling leads to decreased negative regulation by SOCS1, SOCS3, and CIS,
thereby compromising the induction of tolerance in macrophages and engendering more severe and persistent
inflammatory responses to B. burgdorferi. Importantly, these altered signaling events and the higher cytokine production
observed can be mimicked through shRNA and pharmacological inhibition of p38 activity in CD14-expressing macrophages.
Perturbation of this CD14/p38-MAPK-dependent immune regulation may underlie development of infectious chronic
inflammatory syndromes.
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Introduction
Toll-like receptor (TLR) signaling orchestrates the innate
response to danger-associated molecular patterns (DAMPs)
associated with pathogens and/or select endogenous molecules.
The principal proinflammatory DAMPs of the spirochetal
pathogen Borrelia burgdorferi, the causative agent of Lyme disease,
are triacylated lipoproteins recognized by heterodimers of TLR2
and TLR1 [1]. Such recognition by TLR2 activates the NF-kB,
PI3K/AKT, and MAPK pathways which coordinately regulate
inflammation-associated gene activities responsible for host
defense [2]. Although many aspects of Lyme disease pathogenesis
remain ill-defined, it generally is accepted that clinical manifes-
tations result primarily, perhaps entirely, from the host’s immune
response to spirochetes [3]. In this latter regard, borrelial
lipoproteins are thought to be the chief elicitor of inflammation.
CD14, a GPI-anchored protein expressed by macrophages
(MW) and neutrophils, facilitates pro- and anti-inflammatory
cytokine production in response to a variety of DAMPs. Mice
deficient for CD14 and their MW exhibit hyporesponsiveness
when exposed to DAMPs in the form of a bacterial lysate or
purified agonists such as LPS, lipoproteins, and their synthetic
analogs [4–6]. This hyporesponsiveness has been attributed to the
lower affinity of non-CD14-complexed LPS for TLR4 [7], the
requirement for CD14 in MyD88-independent signaling [8], and/
or the inability of p38, a member of the serine/threonine MAPK
family, to be induced in the absence of CD14 [9]. While the
majority of the literature suggests that CD14 is indispensable for
elaboration of an inflammatory response to its cognate DAMPs
[4–6], we previously reported that both in vitro and in vivo
recognition of B. burgdorferi in the absence of CD14 leads to
exaggerated proinflammatory cytokine production and worsening
disease [10]. However, in contrast to live bacteria, an equivalent
number of lysed spirochetes are approximately 100-fold less
stimulatory and are primarily dependent upon CD14 to initiate an
inflammatory response from MW [10].
At the point of contact between a pathogen and the MW plasma
membrane molecules such as CD14, TLRs, and phagocytic
receptors coalesce into cholesterol-rich detergent-insoluble/deter-
gent-resistant domains or ‘‘lipid rafts’’ [11]. These platforms serve
as an initiating site for innate immune signaling cascades and
bacterial entry into the phagocyte [12–15]. CD14, like other GPI
anchored proteins, may participate in cellular signaling either by
direct association with transmembrane spanning proteins [16]
and/or through regulation of the charge character of the inner
leaflet of the plasma membrane which alters recruitment of
cellular proteins to the lipid-rich domain [17–19]. Following
exposure of host cells to pathogens or their isolated constituents,
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uptake, the action of p38 drives maturation of the phagosome
[21], activates downstream kinases that result in the nuclear
translocation of NF-kB [22], and stabilizes cytokine mRNA [23].
Because the pleiotropic action of p38 is thought to augment
inflammation, the pharmaceutical industry has actively pursued
development of p38 inhibitors for the treatment of inflammatory
disorders [20]. However, through the induction of tolerance [24],
p38 also has an anti-inflammatory role to play by virtue of its
ability to induce suppressors of cytokine signaling 3 (SOCS3) and
IL-10 [25] which negatively regulates pathogen-induced inflam-
mation [26]. Tolerance represents a state of MW unresponsiveness
to perpetual exposure to bacterial stimuli [27,28].
Herein, we advance a mechanistic explanation for how CD14
regulates the intensity and duration of host responses to bacterial
challenge which distinguishes CD14-dependent from -independent
signaling and recognition of live versus lysed B. burgdorferi.U s i n ga
mouse model of Lyme disease, we show that B. burgdorferi-activated
CD14
2/2 MW release significantly more proinflammatory cytokines
and do so in a manner only partially dependent on TLR2. Initial
engagement of receptors (i.e., TLR2 and/or non-TLR2) on the
surface of CD14
2/2 MW by B. burgdorferi leads to the accumulation of
PI3K in lipid rafts resulting in higher phospho-AKT levels, lower p38
activation, decreased SOCS activity, and increased and persistent
inflammation. The perpetual nature of CD14
2/2 MW responses to
spirochetes is a reflection of the cell’s inability to be tolerized via
CD14/p38-dependent SOCS induction. Importantly, inhibition of
PI3K in CD14
2/2 MW restores p38 activity to wild-type levels and
thus reduces TNF-a release in response to B. burgdorferi. Additionally,
inhibition of p38 has the commonly observed effect of suppressing
proinflammatory responses, but only when cells are exposed to lysed
bacteria and not when whole organisms are used as a stimulus.
Collectively, our findings challenge the current paradigm by
supporting the rather provocative notion that CD14 signaling: i) is
entirely dispensable for elaboration of a proinflammatory response to
DAMPs other than lipoproteins, ii) is essential for prolonged p38
activation, and iii) serves a critical function in resolution of
inflammation through induction of tolerance.
Results
CD14 deficiency augments TLR-dependent gene activity
Compared to CD14
+/+ MW, activation of CD14
2/2 cells by B.
burgdorferi results in greater transcription and persistent surface
expression of TLR2 and a concomitant increase in proinflamma-
tory cytokine production, particularly TNF-a ([10] and Figure 1A).
To rule out the potential influence of developmental defects
introduced through genetic mutation of cd14, expression of CD14
by MW was transiently targeted through use of shRNA. A pRS-
shGFP lentiviral expression vector was used to transduce either a
CD14 shRNA or a scrambled control shRNA into CD14
+/+ MW.
At 3 days p.i., a 70% reduction in the MFI of CD14 expression
was observed by flow cytometry (Figure 1B), an effect confirmed
by Western blot analysis (Inset). After incubation with B. burgdorferi,
CD14 shRNA-expressing cells produced markedly higher TNF-a
(Figure 1C), a trend identical to that observed with B. burgdorferi-
activated CD14
2/2 MW (Figure 1A).
To more broadly evaluate the impact of CD14 deficiency on the
MW inflammatory transcriptome, we measured gene activity
associated with TLR signaling. Greater transcription of interleukins
(i.e., il1a, il1b, il2, il6,a n dil12), interferons (i.e., ifnc), chemokines
(i.e., ccl2), growth factors (i.e., g-csf), and proinflammatory lipid
mediators (i.e., cox2) was observed in CD14
2/2 than in CD14
+/+
MW (Figure 1D); many of these genes areassociated withthe NF-kB
signaling pathway. TLR2 transcript levels, but not those of other
TLRs, were elevated 50-fold in CD14
2/2 MW compared to wild-
type cells. Gene induction in CD14
+/+ MW peaked at 3 h and
returned to baseline by 24 h p.i.. In contrast, CD14
2/2 cells more
actively transcribed these genes at 3 h and did so throughout the
course of the experiment (data not shown), suggesting a critical role
for CD14 in downmodulation of inflammation.
B. burgdorferi fails to trigger expression of negative
regulators of TLR signaling in the absence of CD14
The above findings prompted an evaluation of the impact of
CD14 deficiency on negative regulators of TLR signaling which
include competitive inhibitors (e.g., IRAKM), protein phosphatases
[e.g., MAPK phosphatase 1 (MKP1)], and E3 ligases (e.g., SOCSs)
[29]. B. burgdorferi induced significantly higher transcription of socs1
[,3.5-fold by 6 h p.i. (P,0.05)], socs3 [,3.5-fold by 3 h and
,2.5-fold by 6 h (P,0.01)], and cis [,5.6-fold by 3 h (P.0.01)] in
CD14
+/+ cells compared to cells lacking CD14 (Figure 1E).
However, by 24 h p.i. transcription of these negative regulators in
CD14
+/+ and CD14
2/2 MW was indistinguishable. Transcription
of mkp1 and irakm was not significantly different in these cells at any
time point studied (data not shown). Consistent with their
respective transcript levels, increased expression of SOCS1 and
CIS was seen in CD14
+/+ MW, whereas little or no expression was
detected in their CD14-deficient counterparts (Figure 1F). Upon
inhibition of proteosome-mediated degradation of SOCS3 using
MG132 (10 mM), SOCS3 expression only was observed in
CD14
+/+ cells (Figure 1F). Collectively, these findings suggest a
critical role for CD14 in negative regulation of TLR signaling and
implicate SOCS family members in this process.
To discover why negative regulation of TLRs is diminished in
CD14
2/2 cells, we examined the expression of three transcription
factors known to directly or indirectly regulate transcription of socs1,
socs3, and cis [30,31]. B. burgdorferi induced significantly higher
transcription of irf1 in CD14
+/+ than in CD14
2/2 MW (P,0.05)
Author Summary
Macrophages express CD14 which partners with Toll-like
receptor 2/1 to recognize bacterial lipoproteins such as
those of Borrelia burgdorferi, the causative agent of Lyme
disease. In vitro evidence demonstrates that blocking CD14
recognition of bacterial components ablates innate host
cell inflammatory responses. Similarly, blocking down-
stream p38 kinase activity dampens the cellular response
to these same microbial stimuli. This body of work
underpins two well-established paradigms which cite the
primacy of CD14 in facilitating TLR recognition of microbes
to initiate proinflammatory signaling events and the
importance of p38 in augmenting such responses.
However, contrary to these paradigms, our prior study
using a mouse model of Lyme disease demonstrated an
association between CD14 deficiency, increased bacterial
burden, and more severe and persistent disease. Herein,
we provide a mechanistic explanation for this unanticipat-
ed host immune response implicating impaired negative
regulation of inflammatory signaling pathways as an
underlying cause. Consequent to impaired negative
regulation the host becomes ‘‘intolerant’’ of continued
exposure to bacteria and thus mounts a perpetual
inflammatory response to their presence. An intriguing
question raised by these findings is whether individual
differences in the severity and clinical course of infection
might reflect the susceptibility of the patient’s innate
immune system to tolerization.
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PLoS Pathogens | www.plospathogens.org 2 December 2009 | Volume 5 | Issue 12 | e1000687Figure 1. Higher B. burgdorferi-induced inflammatory gene activity is associated with lower SOCS levels in CD14
2/2 MW. A) MW isolated
from CD14
+/+ and CD14
2/2 mice were incubated with B. burgdorferi at a MOI of 10 for 24 h and TNF-a levels in culture supernatant were measured by
CBA. B) Lentiviral transduction was used to knock down CD14 in MW as determined by a reduction in mean fluorescent intensity (MFI) and by Western
blot analysis (inset). C) The lentivirus-treated MW were incubated with B. burgdorferi for 24 h and TNF-a levels were measured as for (A). D) MW isolated
fromCD14
+/+andCD14
2/2 micewereincubatedwithB.burgdorferifor 3,6and24 h.TotalRNAwasisolatedandusedtoperformqPCRforsimultaneous
interrogation of 84 genes associated with TLR signaling. The results presented are the ratio of fold change in HPRT-normalized gene activity in CD14
2/2
versus CD14
+/+ MW and error bars represent SEM calculated on the basis of three independent experiments. E) Total RNA isolated from CD14
+/+ and
CD14
2/2 MW incubated with B. burgdorferi was analyzed by qPCR for socs1, socs3 and cis. Results are presented as fold change over respective mock-
infected control and were normalized with 18S rRNA transcript. F) Equivalent protein from lysed MW were separated by 12% SDS-PAGE, transferred to a
PVDF membrane and probed with antibodies directed against SOCS1, SOCS3, CIS or b-actin. G) Total RNA isolated from CD14
+/+ and CD14
2/2 MW
incubatedwithB.burgdorferiwasanalyzedbyqPCRforirf1, irf7 andstat1. Dottedlinesdenotethe 2-foldovermock changeconsideredsignificantforthe
purposes of interpretation. H) Equivalent protein from lysed MW were subjected to Western blot analysis using antibodies directed against phospho-
specific STAT1 or STAT3, or b-actin. Results represent mean6SEM from three to four independent experiments. *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.ppat.1000687.g001
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in CD14
2/2 MW (P,0.01 and 0.05, respectively) (Figure 1G). No
differences were seen for irf3, stat3,o rstat4 (data not shown).
Additionally, Western blot analysis revealed that levels of phospho-
STAT1 (Figure 1H), but not phospho-STAT3 (data not shown),
were higher in CD14
+/+ than in CD14
2/2 MW. Given their
capacity to upregulate SOCS, the lower irf1 transcript levels and
STAT1 phosphorylation in CD14
2/2 MW is consistent with
reduced SOCS expression observed in these cells.
The inflammatory response to B. burgdorferi is
perpetuated in the absence of CD14
The mouse model of Lyme disease was used to elucidate the
relationship between CD14 signaling, SOCS activity, and disease
progression. Arthritis, an inflammatory hallmark of Lyme disease,
is a self-limiting process in immunocompetent mice that peaks
between 2 and 3 weeks p.i. and typically resolves by 6 weeks [32].
Syringe inoculation of mice with B. burgdorferi resulted in tibiotarsal
joint swelling in CD14
+/+ and CD14
2/2 mice which peaked at 2
weeks p.i.. Distinct from CD14
+/+ joints wherein swelling (which
grossly correlates with arthritis progression) resolved by 3 to 4
weeks p.i., CD14
2/2 joints were more inflamed than their wild-
type counterparts at each time point and remained swollen for the
duration of the experiment (Figure 2A). Consistent with the more
severe and prolonged joint swelling in CD14
2/2 mice, transcrip-
tion of irf1, socs1, and socs3 in joint tissue was greatly reduced
compared to wild-type mice (Figure 2B). Given the elevated
cytokine production (e.g., TNF-a and IFN-c, Figure S3 and [10])
Figure 2. CD14 deficiency is associated with greater inflammation and higher bacterial burden with reduced socs transcription in
response to B. burgdorferi. A) CD14
+/+ and CD14
2/2 mice were infected with 1610
5 B. burgdorferi and tibiotarsal joint thickness was measured at 1
week intervals. The horizontal bars indicate mean thickness for each group and the data are representative of two independent experiments (n=24). B)
Total RNA was isolated from the tibiotarsal joints of CD14
+/+ and CD14
2/2 mice (n=6), an equal amount of RNA was pooled from each joint and 0.5 mg
of pooled RNA was used for preparing cDNA. The cDNA was analyzed by qPCR to determine the levels of irf1, socs1 and socs3 transcript. Results
representmean6SEMfrom twoindependent experiments wherein samples were run in triplicate. *P,0.05, **P,0.01. C) DNAfrom the indicated organs
was collected 6 weeks p.i. and the bacterial burden was determined using TaqmanH probes for flaB of B. burgdorferi; murine nidogen served as a control.
Results represent mean6SEM from two independent experiments (n=24) wherein samples were run in triplicate. *P,0.05, **P,0.01.
doi:10.1371/journal.ppat.1000687.g002
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2/2 mice, one might
have predicted decreased spirochete numbers through enhanced
antimicrobial MW effector functions later (at 6 weeks) in the
disease process; surprisingly, all organs recovered from CD14
2/2
mice at this time point, with the exception of the heart, had
heavier bacterial burdens than those of wild-type animals
(Figure 2C). A similar increase in Lyme disease susceptibility
characterized by increased tibiotarsal joint thickness (Figure S1),
enhanced production of pro-inflammatory cytokines (Figure S2),
and greater bacterial burden (Table S1) also was observed in
CD14
2/2 C57BL/6 mice. These results are particularly note-
worthy as C57BL/6 mice are highly resistant to the development
of Lyme pathology [33], and corroborate the importance of CD14
in host immunity irrespective of inherent differences in disease
susceptibility.
Killing, but not internalization, of B. burgdorferi by MW is
impaired in the absence of CD14
To determine whether the hyper-responsiveness of CD14
2/2
MW (Figure 1A) and/or increased bacterial burden in CD14
2/2
mice (Figure 2C) reflected differences in binding and uptake of
spirochetes we evaluated phagocytosis using GFP-expressing B.
burgdorferi. The role of CD14 in the binding and/or internalization
of spirochetes by MW was evaluated by flow cytometry and two-
photon laser scanning confocal microscopy. CD14
+/+ and
CD14
2/2 MW were incubated at 4uC and 37uC for 6 h with or
without GFP-labeled B. burgdorferi at a MOI of 10; this allowed for
discrimination between binding of the spirochete to the cell surface
and active phagocytosis. At 4uC, a temperature which impairs
bacterial uptake, the absence of CD14 had no effect on either the
percentage of cells positive for GFP or the MFI of the positive
population (Figure 3A). Similarly, at 37uC, a temperature
permissive for uptake of bacteria, MW of both genotypes bound
and phagocytosed an equivalent number of spirochetes. Compa-
rable results were obtained when a MOI of 100 was used (data not
shown). The phagocytic index was calculated as described
elsewhere [34], and confirmed that the absence of CD14 does
not alter the capacity of MW to bind and internalize B. burgdorferi
(Figure 3B). Flow cytometry results were corroborated through
visualization of spirochetes bound to the cell surface and found
within the cell’s interior using two-photon laser confocal
microscopy. For these experiments a MOI of 100 was used to
increase the number of organisms per field. The distribution of
spirochetes associated with CD14
+/+ and CD14
2/2 MW was
identical as determined by color depth coding analysis of images of
spirochetes (which are green) within the middle optical sections of
the Z-stack of cells (Figure 3C) and as seen in entire optical Z-stack
for wild-type and CD14
2/2 MW (Video S1 and S2, respectively).
The amount of green signal as a percentage of the total area
represents a measure of internalized spirochetes and was found to
be similar in both CD14
+/+ and CD14
2/2 MW (Figure 3D).
Though more sparsely populated with spirochetes, similar results
were obtained visualizing MW monolayers incubated with B.
burgdorferi using a MOI of 10 (data not shown).
Although differences in binding and phagocytosis were not
observed, the antimicrobial effector functions of CD14
+/+ and
CD14
2/2 MW might differ and thus explain the differential in vivo
bacterial burden (Figure 2C). Killing of bacteria within the
phagolysosomal compartment depends, at least in part, on the
production of RNS/ROS [35,36]. Assessing gene activity both in
vitro and in vivo it was observed that inos transcript levels were
significantly higher in cells and joints from CD14
+/+ mice
(Figure 3E and F, respectively). Though not directly linked
experimentally these differences might underlie the two-fold more
culturablespirochetesbeingrecoveredfrom6 h-infectedCD14
2/2
(7,252 bacteria/ml) versus CD14
+/+ (3,567 bacteria/ml) MW as
measured using a modified tissue culture-infective dose method. In
consequence, prolonged survival of B. burgdorferi internalized by
CD14
2/2 MW might correlate with their persistence in vivo.
CD14 signaling regulates activation of the p38-MAPK
pathway
p38-STAT1-IRF1 signaling positively regulates socs activity
[26,30] and negatively regulates tlr2 activity [37]. To determine
whether CD14 signaling modulates this axis, the phosphorylation
state of p38 was evaluated in CD14
2/2 MW. In contrast to cells
expressing CD14, detectable levels of phospho-p38 were observed
only transiently in B. burgdorferi-stimulated CD14
2/2 MW
(Figure 4A). This result was confirmed and extended using the
phospho-specific Cytometric Bead Array (CBA) assay which
showed that B. burgdorferi stimulated higher phospho-p38, but not
phospho-Erk or Jnk, levels in CD14
+/+ than in CD14
2/2 MW
(data not shown). The dependence of p38 activation on CD14 was
confirmed using the shRNA targeting strategy described above. As
seen in Figure 4B, CD14 shRNA, but not a scrambled shRNA
control, dampened the B. burgdorferi-induced phosphorylation of
p38.
Pharmacological inhibition of p38 has implicated this molecule
in proinflammatory responses to a variety of microbial, host, and
environmental stimuli [20]. Thus, the coexistence of higher levels
of phospho-p38 with lower cytokine production by B. burgdorferi-
stimulated CD14
+/+ MW is contrary to much of the published
literature. To clarify the role of p38 in our model, arctigenin (a
general MAPK inhibitor) and SB202190 (a p38-specific inhibitor)
were used. Both inhibitors significantly lowered the transcription
of inos and socs3 in response to B. burgdorferi (Figure 4C), thereby
relieving the SOCS-mediated inhibition of TNF-a release by
wild-type cells (Figure 4D), an effect that was dose-dependent
(Figure 4E). Enhanced TNF-a release also is observed with
another p38-specific inhibitor, SB203580, but not when cells were
co-incubated with a borrelial lysate (10 mg/ml) (Figure 4F). This
latter finding is reflective of the widely-reported observation that
p38 inhibition ablates cellular inflammatory responses to isolated
bacterial DAMPs [22,38–41] and underscores the difference
between stimulation of cells with live spirochetes as opposed to
spirochetal lysates or lipoproteins [10,22,42,43].
CD14 deficiency alters PI3K recruitment to the lipid raft,
AKT activity, and downstream p38 signaling
p38 is negatively regulated by AKT, a serine-threonine kinase
activated via PI3K [44,45]. To determine whether the diminished
p38 activity in CD14
2/2 MW simply reflected AKT function, the
levels of phospho-AKT were measured in B. burgdorferi-activated
MW. The phospho-AKT pool in CD14
2/2 MW was significantly
increased above baseline and beyond that seen in cells expressing
CD14 (Figure 5A). Of note, peak phosphorylation of AKT in
CD14
2/2 cells (seen at 5 min) immediately preceded the
disappearance of phospho-p38 (Figure 4A, 10 min) suggesting a
strict regulatory network. The PI3K inhibitors wortmannin and
Ly294002 were used to determine whether elevated AKT activity
was responsible for the decreased phospho-p38 levels in CD14
2/2
MW. As shown in Figure 5B, exposure of cells to either inhibitor
reduced the phospho-AKT pool. Blocking PI3K-dependent AKT
function via Ly294002, but not wortmannin, resulted in a ,2-fold
increase in the phospho-p38 pool following co-incubation with B.
burgdorferi (Figure 5B). The inability of wortmannin to have the
same effect as Ly294002 may be attributable to its known ‘‘off
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PLoS Pathogens | www.plospathogens.org 5 December 2009 | Volume 5 | Issue 12 | e1000687Figure 3. B. burgdorferi-induced transcription of inos, but not phagocytic uptake of spirochetes, is impaired by CD14 deficiency. A)
MW were incubated with GFP-expressing B. burgdorferi at a MOI of 10 at 4uC and 37uC for 6 h. Phagocytosis of B. burgdorferi was determined by flow
cytometry. B) Phagocytic indices were calculated based upon the results of five independent flow cytometric experiments. C) MW were incubated
with GFP-expressing B. burgdorferi at a MOI of 100 for 6 h and the cytoplasm and nucleus were stained with wheat-germ agglutinin-Alexa Fluor 647
and DAPI, respectively. Optical sections were collected at every 0.5mm and were used to generate orthogonal sections (upper panel), depth coded
images (middle panel) and green color extraction (lower panel) (see Methods). D) The green area of 10 randomly chosen fields from both genotypes
was used for statistical analysis. E) inos transcript levels were determined by qPCR using RNA isolated from MW incubated with B. burgdorferi or F)
using RNA pooled from joints isolated from infected mice, as described in Figure 2. Results represent mean6SEM from two to five independent
experiments. **P,0.01, ***P,0.001.
doi:10.1371/journal.ppat.1000687.g003
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PLoS Pathogens | www.plospathogens.org 6 December 2009 | Volume 5 | Issue 12 | e1000687Figure 4. CD14 deficiency results in dysregulated p38-MAPK signaling and cytokine production in response to B. burgdorferi. A)
Equal protein from lysates of CD14
+/+ and CD14
2/2 MW incubated with B. burgdorferi were separated by 10% SDS-PAGE, transferred to a
nitrocellulose membrane and probed with phospho-p38 and b-actin antibodies. B) CD14 was knocked down using lentiviral transduction as in
Figure 1B & C. MW were incubated with B. burgdorferi for 30 min and phospho-p38 and b-actin were detected as in Figure 4A. C) CD14
+/+ MW were
treated with DMSO, SB202190 (0.5 mM) or arctigenin (1 mM) for 30 min prior to incubation with B. burgdorferi and total RNA was analyzed by qPCR for
inos and socs3. D) CD14
+/+ MW were treated as described in (C), and culture supernatants were analyzed for TNF-a by CBA. E) CD14
+/+ MW were
treated with DMSO or increasing concentrations of arctigenin or SB202190 for 30 min prior to incubation with B. burgdorferi. Cell culture supernatants
were collected 24 h p.i. and TNF-a was measured by CBA. F) CD14
+/+ MW were treated with DMSO or increasing concentrations of SB203580 for
30 min prior to incubation with live B. burgdorferi or B. burgdorferi lysate (10mg/ml). Cell culture supernatants were assayed for TNF-a by CBA. Results
represent mean6SEM from two to five independent experiments. *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.ppat.1000687.g004
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PLoS Pathogens | www.plospathogens.org 7 December 2009 | Volume 5 | Issue 12 | e1000687Figure5.InhibitionofB. burgdorferi-inducedAKTactivationinCD14
2/2MWreestablishesp38activityand restoresnegativeregulation
ofcytokine production. A) Equal protein fromlysed CD14
+/+ and CD14
2/2 MW incubated withB. burgdorferi were separatedby SDS-PAGE, transferred
toanitrocellulosemembraneandprobedforphospho-AKTandb-actin.B)CD14
2/2 MWweretreatedwithDMSOorPI3Kinhibitors[wortmannin(100nM)
or Ly294002 (100mM)] for 30 min prior to incubation with B. burgdorferi. Western blots were probed with phospho-specific AKT and p38 antibodies, then
striped and reprobed for total AKT, p38 and b-actin. C) CD14
2/2 MW were treated with Ly294002 (100mM) for 30 min prior to incubation with B.
burgdorferi for 3 and 6 h. Culture supernatants were assayed for TNF-a by CBA. TNF-a release by stimulated CD14
+/+ MW served as a control. D) CD14
2/2
MW were treated with DMSO or LY294002 for 30 min prior to incubation with B. burgdorferi. Culture supernatants were collected 24 h p.i. and TNF-a was
measured by CBA. E) Lipid rafts were isolated from CD14
+/+ and CD14
2/2 MW incubated with or without B. burgdorferi at a MOI of 10 for 5 min. An equal
volume of lipid raft and cytosolic fractions were separated by 10% SDS-PAGE, transferred to a nitrocellulose membrane and probed with antibodies
directed against PI3K, flotillin-1, and b-actin. Results represent mean6SEM from two to five independent experiments. ***P,0.001.
doi:10.1371/journal.ppat.1000687.g005
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how signaling through the PI3K/AKT axis influences B.
burgdorferi-induced CD14
2/2 MW activation, spirochetes were
incubated with cells that were untreated or treated with Ly294002.
Enhanced phosphorylation of p38 (Figure 5B) correlated with a
profound reduction in B. burgdorferi-induced TNF-a secretion
(Figure 5C), an effect that was dose-dependent (Figure 5D).
Similar results were obtained with the use of another PI3K
inhibitor, PI-103 [47], (data not shown). Perturbation of the
PI3K/AKT/p38 axis in CD14
2/2 MW reduced cytokine
production to the level observed in CD14
+/+ cells (Figure 5C).
PI3K translocates from the cytosol to the inner leaflet of the
plasma membrane (i.e., cytoplasmic face of the lipid raft) upon
activation of MW by various DAMPs [48]. Given the capacity of
PI3K to phosphorylate AKT we characterized the composition of
the lipid raft formed during the interaction of B. burgdorferi with
CD14
+/+ and CD14
2/2 MW to uncover the mechanism(s)
whereby the phospho-AKT pool is greater in cells lacking
CD14. Lipid raft and non-raft fractions were isolated from cells
incubated with or without B. burgdorferi for 5 min. The lipid raft
and cytosolic fractions were probed for PI3K, flotillin-1 (a lipid raft
marker), and actin (a cytosolic marker). The only lipid raft fraction
to contain significant amounts of PI3K was from the CD14
2/2
MW incubated with B. burgdorferi (Figure 5E). Some flotillin-1 was
present in the non-raft fraction of both cell types following
incubation with B. burgdorferi and likely is due to tethering of the
lipid raft to the actin cytoskeleton during phagocytosis [49], which
would inhibit the ability of those rafts to float on a sucrose
gradient. These data suggest that regulated localization of PI3K
(and likely other molecules) to B. burgdorferi-induced lipid rafts links
proximal membrane events to distal intracellular signaling
cascades.
In the absence of CD14, B. burgdorferi-stimulated
cytokine production is both dependent and independent
of TLR2 and PI3K signaling
Coordinate signaling through CD14 and TLR2 activates PI3K,
NF-kB, and p38-MAPK pathways [2,50] to orchestrate both the
initiation and resolution of inflammatory responses to B. burgdorferi.
CD14 deficiency alters PI3K localization to lipid rafts and
excessive phosphorylation of AKT along with higher transcription
and surface expression of TLR2 is the result. Since TLR2
signaling regulates PI3K activity and leads to AKT activation [2],
we asked whether higher TNF-a production by B. burgdorferi-
stimulated CD14
2/2 MW depends upon TLR2-mediated activa-
tion of AKT and/or engagement of another non-TLR2
receptor(s). To better appreciate the individual and combined
contribution of CD14 and TLR2 signaling to the MW response to
B. burgdorferi, mice deficient for CD14 or TLR2 (each backcrossed
10 generations onto a C3H/HeN background) were crossed to
establish animals that are homozygous recessive for both loci. MW
expressing CD14 and TLR2 and those deficient for individual or
both loci were co-incubated with spirochetes and TNF-a levels
were measured (Figure 6A). In the absence of CD14, TNF-a
production was significantly higher compared to their wild-type
counterparts at 24 h p.i.. TLR2 deficiency had the opposite effect
insofar as release of TNF-a (Figure 6A) and other cytokines (data
not shown) was significantly reduced compared to wild-type MW.
Despite this reduction, cytokine release by TLR2
2/2 MW was
greater than that observed with unstimulated control cells
(P,0.01), implicating the existence of a TLR2-independent
pathway, one that may or may not be triggered by non-lipoprotein
spirochetal constituents. Interestingly, the cell’s capacity to secrete
TNF-a in the absence of both TLR2 and CD14 was partially or
fully restored to the levels released by CD14
2/2 and wild-type
MW, respectively. Restoration of TNF-a production by CD14
2/2/
TLR2
2/2 MW further supports the notion that B. burgdorferi-
induced signaling is not solely dependent upon TLR2 signaling,
nor is CD14 signaling as demonstrated by the phenotypic
difference in cytokine response observed between TLR2
2/2 MW
and CD14
2/2/TLR2
2/2 MW (Figure 6A). These findings raise
the intriguing question of what ultimately controls cytokine
production in the absence of both the CD14 and TLR2 pathways.
As seen in Figure 6B, production of a variety of cytokines by
CD14
2/2/TLR2
2/2 MW is ablated in the absence of PI3K
activity. This result suggests that both TLR2-dependent and -
independent activation of PI3K contributes to the hyper-
inflammatory state in CD14
2/2 MW induced by B. burgdorferi.
More broadly, it also demonstrates that, notwithstanding similar-
ities in the exaggerated Lyme disease phenotype observed in
CD14
2/2 and TLR2
2/2 mice [51,52], these two signaling
pathways are not entirely synonymous.
CD14 licenses MW to become tolerant to perpetual
bacterial stimulation
TLR activation of MW concomitantly triggers cytokine
production and its negative regulation to temper the extent and
duration of inflammation thereby mitigating immunopathology.
Given the role of p38 in the induction of tolerance [24] and the
observation that B. burgdorferi induces lower p38 activity in
CD14
2/2 MW, we asked whether these cells fail to become
tolerant to perpetual stimulation by spirochetes. To address this
question, CD14
+/+ and CD14
2/2 MW were incubated with
medium alone or B. burgdorferi at a MOI of 10 for 12 h. Afterwards,
cells were extensively washed and reexposed to B. burgdorferi at a
MOI of 10 for an additional 6 h (Figure 7A). Upon primary
exposure, cells lacking CD14 secreted significantly more TNF-a
than their wild-type counterparts (P,0.05). Also as anticipated,
CD14
+/+ MW receiving a primary exposure (non-tolerized)
released significantly more cytokine than cells which were
reexposed to spirochetes (tolerized) (P,0.001). In contrast, the
amount of TNF-a produced by CD14
2/2 MW receiving a
primary exposure to B. burgdorferi was identical to that released by
cells after reexposure and significantly greater than that released
by tolerized CD14
+/+ cells (P,0.001). These data support a novel
and indispensable role for CD14-dependent p38 regulation of MW
function through the induction of tolerance to natural bacterial
infection.
Discussion
Coordinate signaling through CD14 and TLR2 orchestrates
both the initiation and resolution of inflammatory responses to B.
burgdorferi. During natural infection, initiation of the host response
begins with CD14 recognition of borrelial lipoproteins and
subsequent activation of TLR2 [10,52,53]. As described herein
and elsewhere [10], the absence of CD14 results in greater
bacterial burden, more severe histopathology, and dysregulated
production of a variety of immunomodulators. Contrary to current
thinking, we demonstrate that CD14 signaling is dispensable for
the induction of inflammation and, instead, tempers the intensity
(e.g., cytokine levels) and duration (e.g., joint swelling) of innate
inflammatory responses to B. burgdorferi. In the face of continued
exposure to stimuli of bacterial origin this inflammatory
‘‘temperance’’ reflects negative regulation of TLR signaling which
tolerizes MW via the action of SOCS. In turn, SOCS activity is
modulated via the PI3K/AKT/p38-MAPK pathway. The
initiation of these signaling events occurs at the contact surface
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PLoS Pathogens | www.plospathogens.org 9 December 2009 | Volume 5 | Issue 12 | e1000687Figure 6. TLR2 plays a partial role in both CD14-dependent and -independent cytokine production. A) MW isolated from CD14
+/+,
CD14
2/2, TLR2
2/2 and CD14
2/2/TLR2
2/2 mice were incubated with B. burgdorferi and culture supernatants were assayed for TNF-a by CBA. B) B.
burgdorferi was incubated with MW isolated from CD14
2/2/TLR2
2/2 mice in the presence of DMSO or 100mM Ly294002 for 24 h and cytokines were
measured by CBA. Results represent mean6SEM from three independent experiments. ***P,0.001.
doi:10.1371/journal.ppat.1000687.g006
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PLoS Pathogens | www.plospathogens.org 10 December 2009 | Volume 5 | Issue 12 | e1000687Figure 7. CD14-dependent signaling is a requirement for B. burgdorferi-induced tolerance in MW. A) CD14
+/+ and CD14
2/2 MW were
incubated with B. burgdorferi at a MOI of 10 for 12 h (primary exposure). Cell monolayers were washed extensively followed by reexposure (secondary
exposure) to medium containing B. burgdorferi for an additional 6 h. The TNF-a level in culture supernatants from cells rexposed to spirochetes was
compared with levels released by MW which received only a primary exposure to B. burgdorferi. B) A schematic diagram illustrating CD14-dependent
and -independent signaling events in response to B. burgdorferi. In the absence of CD14 neither binding nor uptake of B. burgdorferi via a putative
Phagocytic Receptor ‘‘Y’’ is affected. However, localization of PI3K to the signaling platform is altered, perhaps owing to the presence of Receptor ‘‘X’’,
which increases the pool of phospho-AKT resulting in only transient p38 activity. Impaired p38 activity correlates with increased transcription and
expression of TLR2, reduced activation of STAT1 and IRF1, and decreased induction of SOCS, all of which are necessary to modulate the intensity and
duration of Lyme borreliosis. Ultimately, it is CD14-dependent induction of p38-mediated SOCS activity which regulates the intensity and duration of
macrophage response to B. burgdorferi through the induction of tolerance. The size of the red circles indicates the degree of phosphorylation of the
indicated molecule and the size of the individual molecules is reflective of relative transcript/protein levels. The thickness of lines in the model reflects
the intensity of the positive or negative action on downstream molecules.
doi:10.1371/journal.ppat.1000687.g007
CD14 Signaling Induces p38-Dependent Tolerance
PLoS Pathogens | www.plospathogens.org 11 December 2009 | Volume 5 | Issue 12 | e1000687between the spirochete membrane and that of the phagocyte
(Figure 7B).
Despite the fact they comprise only 0.5% of eukaryotic cellular
proteins, GPI-anchored polypeptides (e.g., CD14) have diverse
roles in cellular physiology - from contributing to cell development
and viability to host cell defense against microbial insults [54].
Due to the hydrophobic nature of GPI-anchors such proteins
constitutively reside in cholesterol-rich detergent-insoluble/deter-
gent-resistant membranes [55,56]. These lipid rafts serve as
signaling platforms for various receptors, the best example of
which is the T-cell receptor (TCR). Lacking an extended
cytoplasmic tail, the TCR resides outside lipid rafts until engaged
through recognition of MHC-peptide complex displayed on
antigen presenting cells [57]. Upon ligand binding, the TCR is
recruited to the lipid raft where it associates with kinase signaling
components such as Lck and Lat. With TCR engagement there is
a concomitant exclusion of the phosphatase CD45 from the lipid
raft to prevent inactivation of kinases in the signaling platform
[57]. Accumulating evidence suggests that lipid rafts also are
important in initial bacterial and viral recognition and internal-
ization of pathogens by the MW [58]. Depending upon the ligand,
different receptor components, adaptor proteins, and kinases/
phosphatases coalesce within lipid rafts along with CD14 and
TLRs to orchestrate cellular responses to DAMPs [59]. Engage-
ment of receptors residing within the lipid raft alters the surface
potential of the inner leaflet of the plasma membrane thus
regulating recruitment of non-receptor dependent signaling
molecules (e.g., PI3K) [60,61]. We found that following activation
by B. burgdorferi, significantly more PI3K is recruited to the lipid
rafts of MW which lack CD14 than those expressing CD14. Thus,
PI3K appears to link the spirochete-MW plasma membrane
‘‘interaction’’ platform with the AKT/p38-MAPK pathway within
the cytosol. Perhaps analogous to the partitioning of CD45 during
TCR signaling, it is intriguing to speculate whether a specific
protein(s) is excluded from and/or recruited to the lipid raft
depending on whether CD14 is present or absent. Such a
protein(s) is represented as ‘‘Receptor X’’ in our model (Figure 7B).
In the former case exclusion of a protein(s) may eliminate a
necessary docking partner for PI3K (e.g., Src kinases/c-Kit, [48])
and in the latter case, a protein(s) might actively prohibit entry of
PI3K into a CD14-containing lipid raft. Alternatively, differential
distribution of lipids may distinguish the initiation of signaling
within CD14-containing and -deficient lipid rafts [62]. As an
example, receptors are differentially recruited into ceramide-
versus cholesterol-rich lipid rafts [63].
Upon binding of pathogens to the phagocyte surface, receptor-
dependent cytoskeletal rearrangements occur via recruitment of
actin-related proteins to the lipid raft, a necessary prelude to
internalization of B. burgdorferi [64]. A variety of molecules have
been implicated in the process of binding and phagocytosis of
spirochetes including members of the integrin family such as a3b1,
a4b3, and CD11b/CD18 [65–70], and the cytosolic adapter
protein MyD88 [64,71,72]. A report that CD14 acts as a unique
phagocytic receptor for Gram-negative bacteria [73], suggested
that this molecule might serve a similar function in spirochetal
uptake. However, we found that CD14
+/+ and CD14
2/2 MW
were equally adept at binding and internalizing B. burgdorferi.A s
such, a Phagocytic Receptor ‘‘Y’’ (Figure 7B) of unknown identity
acts in tandem with/without CD14 to concomitantly initiate
spirochetal uptake and innate immune signaling in a TLR2-
dependent and -independent fashion. Importantly, live spirochetes
versus lysates appear to exhibit a differential capacity to engage
Phagocytic Receptor ‘‘Y’’ which underlies why equivalent
amounts of each stimulus elicit different amounts of cytokine
[10,22,42,43], and perhaps why p38 plays a dichotomous role in
regulating the TNF-a production described herein. Despite similar
spirochetal uptake, greater recovery of bacteria from infected
CD14
2/2 MW and mice suggested differential killing of B.
burgdorferi in the presence or absence of CD14. Bacterial killing
within MW occurs by two principal means: i) the generation of
RNS/ROS which reduces phagosomal pH thus facilitating their
fusion with lysosomes and ii) the production of antimicrobial
peptides [35]. Several recent in vitro studies demonstrate the
susceptibility of B. burgdorferi to RNS/ROS [74–77]. Additionally,
in vivo studies have shown that RNAi suppression of tick salivary
proteins capable of neutralizing RNS/ROS at the vector-host-
pathogen interface increase the survival of spirochetes in skin and
facilitate their dissemination throughout the host [78–80].
Consistent with this latter finding the higher bacterial burden
observed in CD14
2/2 MW and mice is associated with lower in
vitro and in vivo transcription of inos. Release of antimicrobial
peptides by human MW is triggered by p38-dependent vitamin D3
receptor (VDR) signaling [81–85]; however, whether the same
regulatory network exists in mouse MW is unclear. Interestingly,
transcription of vdr was dramatically lower in CD14
2/2 MW than
in their wild type counterparts (data not shown). Thus differential
transcription of inos and vdr may explain, at least in part, the
impaired ability of CD14
2/2 mice to clear spirochetes from
infected organs. Differential transcription of inos, vdr, socs, and
phosphorylation of STAT1 suggest the involvement of p38-
MAPK, which controls all these events in MW.
AKT has pleiotropic effects that include promotion of cell
survival, NF-kB activation, and inhibition of ASK1, a MAPKKK
responsible for p38 activity [44,45]. p38 activity is associated with
NF-kB activation and stabilization of mRNA encoding proin-
flammatory cytokines such as TNF-a [23]. The observation that
inhibition of PI3K prevented phosphorylation of AKT and thus
increased p38 activity in B. burgdorferi-activated CD14
2/2 MW is
consistent with the inverse relationship between AKT and p38
activity [44,45]. Unexpectedly, PI3K inhibition also resulted in
decreased TNF-a production, a finding inconsistent with higher
p38 activity and its ‘‘accepted’’ role as a proinflammatory
mediator [20]. Nevertheless, also consistent with our finding,
direct inhibition of p38 in B. burgdorferi-stimulated CD14
+/+ cells
with either general or specific antagonists resulted in lower inos and
socs3 transcription and a dose-dependent increase in TNF-a. This
provocative finding was further supported by the ability of shRNA
to suppress CD14 expression in MW thereby reducing phosphor-
ylation of p38 and increasing TNF-a release in response to
spirochetes. Finally, in a murine model of Lyme borreliosis
transient inhibition of p38 through use of inhibitors was found to
increase B. burgdorferi-induced carditis and is associated with a
higher bacterial burden in infected tissues [personal communica-
tion; Dr. Juan Anguita, Ph.D., (Veterinary & Animal Sciences,
University of Massachusetts, Amherst)]. This altered disease
phenotype is reminiscent of the increased histopathology and
higher bacterial burden in the infected tissues of CD14
2/2 mice
whose MW only transiently produce active p38 following
activation by B. burgdorferi.
Contrarily, p38 inhibition reduces TNF-a secretion by the
mouse RAW264.7MW cell line in response to borrelial lysates [22].
We too report that inhibition of p38 in CD14
+/+ MW reduced
TNF-a production in response to borrelial lysates, but not live
spirochetes, and did so in a dose-dependent fashion. One potential
explanation for the contradictory finding that p38 inhibition
augments the inflammatory response to live bacteria and
suppresses the response to lysates is that the context in which
bacterial DAMPs are recognized influences the downstream
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idea, several studies have demonstrated that live versus lysed
spirochetes (wherein molar equivalency of the two stimuli is
established) elicits a differential cytokine response from MW of
mouse and human origin [10,42,43,86]. The anti-inflammatory
capacity of p38 is further demonstrated in mouse models of
pneumococcal pneumonia and tuberculosis where its inhibition
results in impaired bacterial clearance and increased TNF-a
production both in vitro and in vivo [87]. It also has been established
that p38 induces the shedding of TNF receptor-1 from activated
cells thus dampening their responsiveness to TNF-a [88]. The
combination of increased TNF-a production and maintenance of
its cognate receptor on the cell surface likely contributes to the
cytokine ‘‘surge’’ and exacerbates the pathology associated with
bacterial infection. Taken together, these results challenge the
notion that disaggregated or isolated DAMPs (e.g., lysates, purified
LPS, lipoproteins, etc.) are equivalent to the whole organisms from
which they are generated [10,24]. They also sound a cautionary
note regarding application of p38 inhibitors to treat inflammatory
disorders, especially those of infectious origin, wherein blockade of
this signaling pathway may exacerbate rather than ablate
inflammation. Development of immunotherapeutic strategies that
enhance the action of SOCS may represent a more fruitful avenue
in pursuit of novel anti-inflammatory drugs [31,89–91]. Despite
the concordance of results described above it also must be
acknowledged that commonly used inhibitors of PI3K and p38
demonstrate off-target effects including blockade of other kinases
and phagocytosis when used at high concentrations. In the present
study, the use of inhibitors at low concentrations partially mitigates
the likelihood of such off-target effects, however, left unclear is
their potential impact on phagocytosis of B. burgdorferi and
subsequent cytokine release by host cells. Further complicating
this issue is the existence of eight isoforms of PI3K and four
isoforms of p38. The relative contribution of different isoforms to
activation of host cells and the influence of exposure to live versus
lysed spirochetes on signaling are currently under investigation
employing a shRNA strategy that will obviate concerns raised by
non-specificity.
A correlative relationship exists between phagocytosis of bacteria
and cytokine release [92]. For example, MyD88 deficiency impairs
both uptake of B. burgdorferi by mouse MW and subsequent
transcription of tnfa and il6 [72]. Under other circumstances (i.e.,
TLR2 deficiency), while uptake of spirochetes by MW was
unaffected, the transcription of a variety of cytokine and chemokine
genes was significantly reduced [72]. Similarly, we found that
CD14
+/+ and CD14
2/2 MW were equally adept at binding and
internalizing B. burgdorferi and cytokine secretion was altered;
however, in this case, the proinflammatory response of MW lacking
CD14 was significantly greater than that seen with their wild-type
counterparts. Differences in TNF-a levels might simply reflect the
greater survival/persistence of spirochetes within and expression of
TLR2 by CD14
2/2 versus CD14
+/+ MW, either or both of which
could potentiate cytokine secretion. However, evidence provided by
in vivo experiments argues against cytokine secretion being directly
linked to spirochetal burden insofar as higher cytokine levels in the
serum of CD14
2/2 mice at 1 and 3 week p.i. (Figure S2) precedes
the significant differences in bacterial burden observed at 6 weeks
(Table S1). We propose that the aforementioned response is more
likely a reflection of the inability of B. burgdorferi to induce tolerance
in MW lacking CD14 which, in turn, results from impaired p38-
mediated SOCS activity. Trace amounts of DAMPs can impose
tolerance on MW thus making them less or unresponsive following
subsequent reexposure to stimuli of an identical or similar (cross-
tolerization) nature [93,94]. Relevant to the phenomenon of
tolerance, Dennis et al. reported that recognition of B. burgdorferi
activates SOCS [95] and Diterich et al. showed that B. burgdorferi can
tolerize MW [96] and induction of tolerance requires p38-mediated
stimulation of SOCS [24,28,97–101]. Here we mechanistically link
these previous findings by showing that CD14 recognition of B.
burgdorferi triggers p38-dependent SOCS activity to impose a
tolerant phenotype within MW. Interestingly, this CD14-dependent
mechanism of tolerance may be operative in the absence of TLR2
as well, a notion supported by the observation that TLR2
2/2 MW
produce significantly less cytokine than when these cells also are
deficient for CD14. Uncontrolled release of proinflammatory
cytokines by cells lacking CD14 likely is further exacerbated by
their diminished production of the anti-inflammatory cytokine IL-
10, which normally would temper such responses (data not shown).
Thus, activation of MW in the absence of CD14 may represent the
‘‘perfect storm’’ of increased bacterial burden and expression of
TLR2 and reduced tolerance to perpetual stimulation by B.
burgdorferi. It is this dysregulated response at the cellular level which
underpins the altered Lyme disease phenotype observed in CD
14
2/2 mice.
In toto, we detail a critical and unanticipated role for CD14 in
downmodulating TLR2-dependent and -independent pathways
which regulate NF-kB signaling events. We provide evidence that
reduced SOCS activity licenses greater cytokine production
through diminished negative regulation of the TLR2 pathway.
CD14 exerts its influence on the intensity and duration of
inflammation through the PI3K/AKT/p38-MAPK axis which
serves as a ‘‘rheostat’’ to finely modulate NF-kB activity, a critical
regulator of the host’s inflammatory response to pathogenic
challenge. An intriguing question raised by these findings is
whether individual differences in the clinical course of infection
might reflect the susceptibility of the patient’s innate immune
system to tolerization.
Methods
Reagents
All buffers and reagents were prepared to minimize contami-
nation with environmental LPS by utilizing baked (180uC for 4 h)
and autoclaved glassware, disposable plasticware, and pyrogen-
free H2O.
Cultivation of B. burgdorferi
Low-passage B. burgdorferi strain 297 were maintained at 23uCi n
Barbour-Stoenner-Kelley medium containing 6% normal rabbit
serum (BSKcomplete) from Pel-Freez Biologicals (Rogers, AR) and
then temperature-shifted to 37uC. Increased expression of OspC
was confirmed by silver staining of whole borrelial lysates
separated by SDS-PAGE. B. burgdorferi 297 expressing green
fluorescent protein were cultivated in BSKcomplete containing
400 mg/ml kanamycin and were grown at 37uC until mid- to late-
logarithmic phase for subsequent use in phagocytosis experiments
as previously described [102]. For the generation of borrelial
lysates temperature shifted bacteria were harvested by centrifuga-
tion at 80006g, washed twice with PBS lacking Ca
++ and Mg
++,
and finally resuspended in PBS. Lysates were prepared by
sonicating the bacteria for 30 s (with three separate 10 s pulses
at 30 s intervals) using a 60-Dismembrator (Fisher Scientific,
Waltham, MA). The total protein content of lysates was
determined using the BCA method.
Mice and infection protocol
Four to eight week-old C3H/HeN (CD14
+/+) mice (Taconic,
Germantown, NY) were housed in the Animal Resources Facility
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libitum and all animal procedures were approved by the
Institutional Animal Care and Use Committee of Albany Medical
College. CD14
2/2 mice were generated as previously described
[6] and subsequently backcrossed 10 generations onto a C3H/
HeN background [10]. TLR2
2/2 mice were provided by Tularik
Inc. (now Amgen Inc., South San Francisco, CA), generated by
Deltagen Inc. (Menlo Park, CA) [103] and were backcrossed 10
generations onto a C3H/HeN background. C3H/HeN mice
deficient for CD14 and TLR2 were crossed to establish animals
that are homozygous recessive for both alleles.
Mice were infected via intradermal administration of 1610
5
spirochetes over the sternum. For some experiments mice were
infected using Ixodes scapularis ticks carrying B. burgdorferi as
previously described [10]. At one week intervals, tibiotarsal joint
thickness was measured using digital calipers and bacterial burden
in infected tissues was determined using isolated genomic DNA as
previously described [10]. Total RNA also was isolated from
infected tissues for qPCR as described below.
Isolation and differentiation of MW
MW were isolated from the bone marrow of six to eight week-
old mice. Briefly, bone marrow cells recovered by flushing femurs
and tibia with DMEM were incubated in tissue culture-treated
25cm
2-flasks (BD Falcon, BD Biosciences, San Jose, CA) overnight
at 37uC with 5% CO2 to eliminate adherent fibroblasts,
granulocytes, and any contaminating MW [104]. The following
day, 1610
7 suspension cells were maintained in 10-cm
2 bacteri-
ological Petri dishes (BD-Falcon) for three days with DMEM
supplemented with 10% fetal bovine serum, 20% L292-cell
conditioned media, 0.01% HEPES, 0.01% sodium pyruvate,
and 0.01% L-glutamine. Cultures were supplemented with 5 ml of
the above-described medium and seven days after isolation cell
monolayers were recovered using ice-cold PBS and scraping.
Single cell suspensions were used immediately or frozen in liquid
nitrogen with 20% FBS and 10% DMSO for use in future
experiments.
B. burgdorferi-MW co-incubation
MW were seeded into 6-well tissue culture-treated plates at a
concentration of 1610
6 cells/2 ml/well and allowed to adhere
overnight. The following day, B. burgdorferi were enumerated and
resuspended as described above. MW were washed twice with
serum-free DMEM to remove any traces of FBS and spirochetes
(resuspended in DMEM + 4% autologous serum) were added at a
MOI of 10 and co-incubated for different time intervals at 37uCi n
5% CO2. Cells incubated with DMEM + 4% autologous serum
alone served as mock-infected controls. For tolerance experiments,
MW were initially incubated with B. burgdorferi at a MOI of 10 for
12 h at 37uCi n5 %C O 2. Supernatants were collected to
determine TNF-a levels by CBA and cells were washed extensively
with pre-warmed serum-free medium before addition of fresh
medium containing B. burgdorferi at the same concentration as used
for the primary exposure. Supernatants were collected after an
additional 6 h of co-culture and TNF-a levels were again
measured.
Quantitative real-time PCR
Total RNA was isolated from MW using the RNeasy Mini Kit
(Qiagen GmbH, Hilden, Germany) as per the manufacturer. The
amount and purity of RNA was quantified by Biophotometer
(Eppendorf AG, Hamburg, Germany) and 0.5mg were used for
reverse transcription of cDNA using Superscript II (Invitrogen
Corporation, Carlsbad, CA). cDNA (20ml) served as the template
in quantitative real-time PCR (qPCR) analysis using Mouse TLR
Signaling Pathway RT
2 Profiler
TM PCR Arrays (SABiosciences,
Frederick, MD). This qPCR methodology directly quantifies
transcript levels based upon the 2
2DDCt method through
measurement of SYBR green fluorescence using an iQ5 real-time
PCR detection system (Bio-Rad Laboratories, Hercules, CA).
For transcriptional analysis of genes not represented on the RT
2
Profiler
TM PCR Array, unique genes were interrogated by qPCR
in a final volume of 25 ml containing: 12.5 mlo f2 6SYBR green
master mix (Bio-Rad Laboratories), 25 pico-moles of forward and
reverse primers, and 0.2 ml of cDNA. Primers were designed using
Beacon Designer version 7.0 software (PREMIER Biosoft Intl,
Palo Alto, CA) and the sequences of specific primer sets are
provided in Table S2. Amplification conditions were 95uC (3 min)
and 40 cycles of 95uC (15 s), 55uC (40 s) and 72uC (30 s). All the
qPCR reactions were run in triplicate with no-template controls
(NTC) and mean cT values were used for all the calculations using
18S rRNA as an internal normalization control. Transcript levels
for infected groups are presented as a fold change over their
corresponding uninfected control group. A greater than two-fold
change with respect to mock control was considered significant.
Western blot analysis
Antibodies directed against SOCS1, SOCS3 and CIS were
obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA),
antibodies against AKT, STAT1, STAT3 and p38 were obtained
from Cell Signaling Technology, Inc. (Danvers, MA), and
antibodies against b-actin were obtained from Bethyl Laborato-
ries, Inc. (Montgomery, TX). Protein samples (25–100mg,
depending on the target) were resolved by SDS-PAGE and
transferred to nitrocellulose using semi-dry transblot (Bio-Rad
Laboratories, Hercules, CA). The membrane was blocked with 5%
non-fat milk and then incubated overnight at 4uC with primary
antibody (1:1000 for AKT and STATs, 1:100 for SOCS, and
1:10,000 for b-actin). Membranes were probed with HRP-
conjugated anti-rabbit IgG (Cell Signaling Technology) diluted
1:2000. Specific signal was developed using the SuperSignal West-
Dura chemiluminescent substrate (Pierce Endogen, Rockford, IL).
Cytometric bead array (CBA) for cytokine and
phospho-protein analysis
Cytokine levels were measured in recovered culture supernatant
using the Mouse Inflammation CBA kit and a FACSArray flow
cytometer [BD Immunocytometry Systems (BDIS), San Jose, CA].
Data was acquired and analyzed using BD FACSArray software
and FCAP Array software, version 1.0 (BDIS), respectively. For
phospho-protein analysis, the protein content of the samples was
normalized, and samples were analyzed using a phospho-specific
CBA kit.
Determination of recoverable live B. burgdorferi from MW
To enumerate B. burgdorferi recovered from CD14
+/+ and
CD14
2/2 MW we used a variation on the classical tissue culture
infective dose (TCID) method used in virology to determine the
viral titer necessary to infect 50% of target cells. Briefly, 5610
4
CD14
+/+ and CD14
2/2 MW were co-incubated for 6 h with B.
burgdorferi at a MOI of 10. The MW were washed with PBS lacking
Ca
++ and Mg
++ and the cells were harvested by scraping. Ten-fold
serial dilutions were made in BSKcomplete media down to 10
27.
Aliquots of 100ml of each dilution were placed in triplicate wells of a
96-well microtiter plate and incubated for 7 days. On the 7
th day
dark field microscopy was used to visualize spirochetes and bacterial
titers were calculated using the Reed-Muench formula [105].
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inhibitors
MW were treated with the inhibitors arctigenin (1mM),
SB202190 (0.5mM), SB203580 (10mM), wortmannin (100nM),
and Ly294002 (100mM) for 30 min prior to addition of B.
burgdorferi at a MOI of 10. In some experiments a range of inhibitor
concentrations was used. DMSO alone served as a control.
Culture supernatants were collected for cytokine measurement
and cells were lysed for RNA isolation and Western blot analysis.
Lipid raft isolation
MW (1610
7) from CD14
+/+ and CD14
2/2 mice were lysed
after 5 min exposure to B. burgdorferi at a MOI of 10 using ice-cold
TNE buffer [10mM Tris (pH 7.5), 150mM NaCl and 5mM
EDTA] containing 1% Triton X-100. Lysates were centrifuged at
48,0006g for 4 h on a sucrose gradient to float the lipid raft
fraction from the non-raft fraction. Fractions (40 ml) were resolved
by SDS-PAGE and analyzed by Western blotting as described
above. Antibodies used at the manufacturer’s suggested concen-
trations included rabbit anti-mouse PI3K (Santa Cruz Biotech-
nology), flotillin-1 (Cell Signaling Technology), and b-actin (Bethyl
Laboratories).
Two-photon laser confocal microscopy
MW were seeded into 8-well chamber slides (Lab-Tek
TM II CC2
Chamber Slide
TM System) at a concentration of 1610
5 cells/
200ml/well and allowed to adhere overnight. The following day,
after staining the cell membrane using wheat germ agglutinin
Alexa Fluor-647, GFP-expressing B. burgdorferi were enumerated
and added to cell monolayers at a MOI of 100 and co-incubated
for different time intervals. The cells were fixed with 1%
paraformaldehyde and were mounted in VECTASHIELDH with
DAPI (Reactolab SA, Servion, Switzerland). Confocal images
were acquired using a Zeiss LSM-510 META-NLO microscope
equipped with argon and HeNe lasers. Optically sectioned images
were acquired using a 406objective (5126512 pixel resolution) at
0.5 mm intervals. Image processing and analysis were performed
using ImageJ (NIH, v1.41b) and LSM Image Browser (Zeiss, v5.0).
Depth coding and green color extraction was used to determine
the area representing internalized GFP-labeled B. burgdorferi. The
hue/saturation was brought up to 100% in Adobe Photoshop and
the green color was extracted, imported into ImageJ and the
percentage of green area was measured.
FACS analysis
MW (5610
5 cells) were aliquoted into 5 ml polystyrene round-
bottom tubes (BD Biosciences, Bedford, MA) and incubated with
GFP-expressing B. burgdorferi resuspended in DMEM+4% autol-
ogous serum at a MOI of 10. Cells and bacteria were co-incubated
for different time intervals at 4uCo r3 7 uC and then processed for
flow cytometric analysis as previously described [10]. Phagocytic
indices were calculated using the formula phagocytic index=(%
GFP
+ cells at 37uC6MFI at 37uC)2(% GFP
+ at 4uC6MFI at
4uC).
Lentiviral transduction
Knock down of CD14 was achieved using a pRS-shGFP
lentiviral expression vector (OriGene Technologies, Rockville,
MD) to transduce either a CD14 shRNA or a scrambled control
shRNA into CD14
+/+ MW. Briefly, ampho packaging cell lines
(Orbigen Inc., San Diego, CA) were transfected with lentiviral
vector expressing scrambled shRNA or shRNA targeting CD14
using a standard calcium phosphate method. Cell-culture
supernatants were collected 48 h post-transfection and titered
virus was added to CD14
+/+ MW in presence of 4mg/ml
Polybrene. The efficiency of suppression of CD14 was assessed
72 h post-viral transduction using flow cytometry and Western
blot analysis.
Statistical analysis
A two-way Analysis of Variance (ANOVA) followed by a Fisher
LSD post-hoc test (InStat 4.0, GraphPad Software Inc., La Jolla,
CA) was used to analyze data presented in Figure 2A. Other data
sets were analyzed for statistical significance using a parametric
two-way ANOVA with a Bonferroni correction if the data was
found to fit a Gaussian distribution (tested using the method
Kolmogorov and Smirnov). When not normally distributed the
data was analyzed for statistical significance using a non-
parametric two-way ANOVA with Mann–Whitney U test. An
a=0.05 level was used to determine whether a significant
difference existed between data from CD14
+/+ versus CD14
2/2
and untreated versus treated groups.
Supporting Information
Figure S1 CD14 deficiency undermines the Lyme arthritis-
resistant phenotype of C57BL/6 mice. CD14
+/+ and CD14
2/2
C57BL/6 mice were infected using Ixodes scapularis ticks carrying B.
burgdorferi and tibiotarsal joint thickness was measured at 1-wk
intervals using digital calipers. The horizontal bars indicate mean
thickness for each group and the data are representative of two
independent experiments (n=24).
Found at: doi:10.1371/journal.ppat.1000687.s001 (0.56 MB TIF)
Figure S2 CD14 deficiency results in increased in vivo cytokine
production in response to B. burgdorferi. CD14
+/+ and CD14
2/2
C57BL/6 mice were tick-inoculated with B. burgdorferi and serum
cytokine levels were measured using CBA at 1, 3, and 6 wks p.i..
Results represent mean6SEM from three independent experi-
ments. **P,0.01, ***P,0.001.
Found at: doi:10.1371/journal.ppat.1000687.s002 (0.22 MB TIF)
Table S1 CD14 deficiency impairs clearance of B. burgdorferi in
C57BL/6 mice. Mice were sacrificed at 1, 3, and 6 wks post tick-
inoculation and DNA was isolated from the indicated tissues for
qPCR analysis as described in Figure 2C and Methods. Results
represent mean6SEM from three independent experiments
(n=10 to 16) wherein samples were run in triplicate. *P,0.05,
**P,0.01.
Found at: doi:10.1371/journal.ppat.1000687.s003 (0.10 MB PDF)
Table S2 Primer sequences used in qPCR.
Found at: doi:10.1371/journal.ppat.1000687.s004 (0.10 MB PDF)
Video S1 Moviesequenceofstacked opticalzsectionofCD14
+/+
MW shown in Figure 3C.
Found at: doi:10.1371/journal.ppat.1000687.s005 (7.30 MB
MOV)
Video S2 Movie sequence of stacked optical z section of
CD14
2/2 MW shown in Figure 3C.
Found at: doi:10.1371/journal.ppat.1000687.s006 (6.50 MB
MOV)
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